Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05205720Phase 4Completed
Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Opioid consumption. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05205720.